Biogen Alzheimer's drug could get Medicare coverage in 2025 if approved, says Dr. Scott Gottlieb

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins 'Squawk Box' to discuss if Biogen's drug is tackling the root cause of Alzheimer's, what scientists are learning from Biogen's Alzheimer's treatment and more. For access to live and exclusive video from CNBC subscribe to CNBC PRO: cnb.cx/2NGeIvi
» Subscribe to CNBC TV: cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
Get the latest news: www.cnbc.com/
Follow CNBC on LinkedIn: cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Instagram: cnb.cx/InstagramCNBC
www.cnbc.com/select/best-cred...
#CNBC
#CNBCTV

[@rottenrabbit]

FDA approval doesn't mean anything. A better statement would be "FDA is getting a huge payoff later today".

[@scillyautomatic]

4 days ago people might have listed to what Scott Gottlieb had to say. After the files #12 dropped... no one trusts him.

[@willtwain1383]

Joe looks like he just got off the couch, mid afternoon on Thanksgiving Day.

[@ashtv6416]

Funny how this corrupt guy is on tv all the time!

[@teebone2157]

Diet related issues caused alzheimers

[@schoolboyd442]

No it doesnt. Site your sources please 🤨

[@Playboysmurf1]

Absolutely BS.
There is a very wide range of people who have get Alzheimers including people with clean diets, and physical health.

[@teebone2157]

It better not get approved

[@alexabouezzi1000]

Why?!?